BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 29, 2013
View Archived Issues
The discovery and preclinical validation of a potent antitumor peptide vaccine
Read More
ONO-6950 shows potential as a novel therapeutic option for bronchial asthma
Read More
Researchers from Kineta present novel broad-spectrum antiviral compounds
Read More
MedImmune presents results for MEDI-565 and MEDI-575
Read More
Medigene and SynCore extend agreement for anticancer candidate
Read More
FDA tests potential universal influenza vaccine
Read More
Analysis of LRG glycosylation allows for improved diagnostic accuracy in HF
Read More
Researchers present preclinical results for leukadherin-1
Read More
New TRPV1 ligands patented by Grunenthal
Read More
New bispecific antibody fusion proteins disclosed by UCB
Read More
Genentech presents new series of BTK inhibitors
Read More
Merck & Co. discloses new mGlu2 receptor antagonists
Read More
Researchers at Theravance design novel HCV NS5A inhibitors
Read More
Cellmid completes acquisition of Advangen
Read More
Phase I/IIa study of dendritic cell-based vaccine for AML meets endpoints
Read More
Arrowhead Research plans phase I study of ARC-520 for chronic HBV infection
Read More
Cellular Dynamics licenses rights to develop cardiomyocyte progenitors for therapeutic use
Read More
FDA grants breakthrough therapy designation to Alexion's asfotase alfa
Read More
Stribild receives European approval
Read More
Nouriast set to launch in Japan
Read More
Pharmstandard increases stake in Biolek
Read More
FDA issues complete response letter for Valeant's efinaconazole
Read More
Omeros plans European phase I study of OMS-721 for atypical hemolytic uremic syndrome
Read More
Aslan reports positive data from phase II ALSAN-001 study
Read More
First clinical study of Bionor Pharma's HIV vaccine candidate Vacc-C5 completes enrollment
Read More
Cenix BioScience to identify predictive biomarkers for Debiopharm's oncology candidates
Read More